Researchers have developed an add-on for laser-scanning microscopes that can improve the quality of 2D and 3D imaging of the brain, according to a new study published in Optica.

With individuals constantly on the go, it’s becoming more of a necessity to have digital access to important medical history information. Texas Health Resources is addressing the need by empowering patients access to their health records through the Apple Health app.

The Office of the National Coordinator for Health Information Technology (ONC) is being called on to develop a voluntary certification program to help improve the usability and safety of pediatric electronic health records (EHRs).

Improving women’s understanding of baseline mammograms and their importance is necessary, according to new research published in the Journal of the American College of Radiology.

Medicaid expansion under the Affordable Care Act (ACA) failed to improve access to care for minorities and low-income patients with complex surgical needs, researchers reported in the Sept. 13 online edition of the Journal of the American College of Surgeons.

Gregg W. Stone, MD, had the unenviable task of condensing the 255-page agenda for next weekend’s Transcatheter Cardiovascular Therapeutics (TCT) meeting into a handful of highlights during a 12-minute media briefing on Thursday, Sept. 13.

From taking swipes at specific drug companies on Twitter to promising to get pharmaceutical prices down “really, really substantially,” President Donald Trump has said a lot about lowering drug prices. However, many Americans aren’t buying into the rhetoric, according to a recent study.

French pharmaceutical company Servier has partnered with Bioserenity to launch a “smart T-shirt” they’re calling the Cardioskin—a wearable innovation that would allow heart patients to monitor their cardiac rhythm throughout the day, the Daily Mail has reported.

Though major medical associations advise against prostate cancer screening in men over the age of 70, treatment in elderly populations costs Medicare more than $400 million a year, according to research published online Sept. 13 in JAMA Oncology. These costs include claims for CT, MRI and bone scans for diagnosis and follow-up imaging.

Researchers found undergoing MRI scans every six months better detected early breast cancer in young women with a high genetic risk for the disease compared to mammograms.